GLP-1 Reduces Heavy Drinking in Clinical Trial Weekly semaglutide with CBT significantly reduced heavy drinking in alcohol use disorder & obesity patients, per a clinical trial. 04 May 2026 #GLP1#AlcoholUseDisorder#Semaglutide#ClinicalTrial#ObesityTreatment
